Remnant-Like Particle Cholesterol May Indicate Atherogenic Risk in Patients on Chronic Hemodialysis

Nephron

Volumn 76, Issue 1, 1997, Pages 7-14

  Oda, Hiroaki ^a   Yorioka, Norialci ^a   Okushin, Sayuri ^a   Nishida, Yoji ^a   Kushihata, Shigeyuki ^a   Ito, Takajumi ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherogenic index; Hemodialysis; Lipid metabolism; Remnant like particle cholesterol

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030961774     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190133     Document Type: Article

References (38)

1. Lowrie EG., Lazarus JM., Mocelin AJ., Bailey GL., Hampers CL., Wilson RE., Merrill JP: Survival of patients undergoing chronic hemodialysis and renal transplantation., N Engl J Med 1973:288:863-867.
2. Tschope W., Koch M., Thomas B., Ritz E., German Study Group Diabetes and Uremia: Serum lipids predict cardiac death in diabetie patients on maintenance hemodialysis., Nephron 1993;64:354-358.
3. D'Elia JA., Weinrauch LA., Gleason RE., DeSil-va RA., Nesto RW: Preliminary screening of the relationship of scrum lipids to survival of chronic dialysis patients., Ren Fail 1993:15: 203-209.
4. Goldstein JL, Ho YK, Basu SK., Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density tipoprotein, producing massive cholesterol deposition., Proc Natl Acad Sci USA 1979;76: 333-337.
5. Steinberg D., Parthasarathy S, Carew TE., Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its alherogenicity., N Engl J Med 1989,320: 915-924.
6. Hoff HF., Beck GJ., Skibinski CL., Jurgens G., O'Neil J., Kramer J, Lytle B: Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients., Circulation 1988:77:1238-1244.
7. Murai A., Miyahara T., Fujimoto N, Matsuda M., Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction., Atherosclerosis 1986;59:199-204.
8. Groot PHE., van Stiphout WAHJ., Krauss XH., Jansen H, van Tol A, van Ramshorst E., Chin-On S, Hofrnan A., Cresswell SR., Havekes L: Postprandial lipoprotein metabolism in nor-molipidemic men with and without coronary artery disease., Arterioscler Thromb 1991:11: 653-662.
9. Nestel PJ, Fidge NH, Tan MH: Increased lipoprotein-remnant formation in chronic renal failure., N Engl J Med 1982;307:329-333.
10. Ron D., Orcn I., Aviram M., Better OS., Brook JG: Accumulation of lipoprotein remnants in patients with chronic renal failure., Atherosclerosis 1983:46:67-75.
11. Kameda K., Matsuzawa Y., Kubo M, Ishikawa K., Maejima I, Yamamura T., Yamamoto A., Tarui S: Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan., Atherosclerosis 1984;51:241-249.
12. Sato T, Hiwatari M., Sato E., Watanabe H, Ya-sujima M: Changes of plasma lipid and lipoproteins by rehabilitation therapy for stroke., Tohoku J Exp Med 1994:172:91-96.
13. Shibasaki T., Nakano H., Matsuda H., Ohno I., Matsumoto H, Misawa T., Ishimoto F., Sakai O: Pravastatin administration to hyperlipidemia in patients with nephrotic syndrome., Jpn J Nephrol 1993:35:1243-1248.
14. Washio M, Nanishi F, Okuda S, Onoyama K., Fujishima M: Alpha tocopherol improves focal glomerulosclerosis in rats with Adriamycin-induccd progressive renal failure., Nephron 1994:68:347-352.
15. Altman PO, Sainuelsson O., Alaupovic P: Lipoprotein metabolism and renal failure., Am J Kidney Dis 1993:21:573-592.
16. Hasler-Rapacz JO., Nichols TC., Griggs TR., Bellinger DA., Rapacz J: Familial and diet-induced hypercholesterolemia in swine: Lipid, ApoB, and ApoA-I concentrations and distributions in plasma and lipoprotein subfractions., Arterioscler Thromb 1994; 14:923-930.
17. Gore I., Tejada C: The quantitative appraisal of atherosclerosis., Am J Pathol 1957;33:875-885.
18. Nakajima K., Saito T, Tamura A, Suzuki M, Nakano T, Adachi M., Tanaka A, Tada N, Nakamura H, Campos E., Havel RJ: Cholesterol in remnant-like lipoproteins in human scrum using monoclonal anti apo B-100 and anti apo A-l immunoaffinity mixed gels., Clin Chim Acta 1993;223:53-71.
19. Campos E, Nakajima K, Tanaka A, Havel RJ: Properties of an apolipoprotein E-enrichcd fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100., J Lipid Res 1992;33:369-380.
20. Mahley RW., Wcisgraber KH., Innerarity TL., Rail SC: Genetic defects in lipoprotein metabolism: Elevation of atherogenic lipoproteins caused by impaired catabolism., JAMA 1991; 265:78-83.
21. Havel RJ., Kita T, Kotite L., Kane JP., Hamilton RL, Goldstein JL., Brown MS: Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit: An animal model of human familial hypercholesterolemia., Arteriosclerosis 1982:2:467-474.
22. Kane JP., Chen GC., Hamilton RL., Hardman DA, Malloy MJ., Havel RJ: Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia., Arteriosclerosis 1983:3:47-56.
23. Havel RJ: Familial dysbetalipoproteinemia., Med Clin North Am 1982;66:441-454.
24. Seed M., Hoppichler F., Rcaveiey D., McCarthy S., Thompson GR., Bocrwinklc E., Utermann G: Relation of scrum lipoprotein(a) concentration and apolipoprotein(a) phenotype of coronary heart disease in patients with familial hypercholesterolemia., N Engl J Med 1990:322: 1494-1499.
25. Mahley RW, Hussian MM: Chylomicron and chylomicron remnant catabolism., Curr Opin Lipid 1991:2:170-176.
26. Mahley RW: Atherogenic lipoproteins and coronary aitery' disease: concepts derived from recent advances in cellular and molecular biology., Circulation 1985;72:943-948.
27. Yamada N, Shames DM., Stoudcmire JB., Havel RJ: Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: Heterogeneity related to the presence of apolipoprotein E., Proc Natl Acad Sci USA 1986;83:3479-3483.
28. Fainaru M., Mahley RW., Hamilton RL., Innerarity TL: Structural and metabolic heterogeneity of P-very low density lipoproteins from cho-lestcrol-fed dogs and from humans with type III hyperlipoproteinemia., J Lipid Res 1982;23: 702-714.
29. Stalenhoef AFH., Malloy MJ, Kane JP., Havel RJ: Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia., J Clin Invest 1986:78:722-728.
30. Murase T, Itakura H: Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats., Atherosclerosis 1981:39:293-300.
31. Goldstein JL., Kita T., Brown MS: Defective lipoprotein receptors and atherosclerosis: Lessons from an animal counterpart of familial hypercholesterolemia., N Engl J Med 1983;309: 288-296.
32. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M., Morii H: Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis., Metabolism 1991:40:1002-1008.
33. Oda H., Yorioka N., Ueda C., Okushin S., Kushi-hata S., Nishida Y., Yamakido M: Scvcrly decreased hepatic triglyceride lipase (HTGL) activity induces abnormal accumulation of intermediate density lipoprotein (1DL), while lipoprotein lipase (LPL) activity remains normal in dialysis patients., J Am Soc Nephrol 1995:6:585 (abstract).
34. Tatami R., Mabuchi H., Ueda K., Ueda R., Haba T., Kametani T, Ito S., Koizumi J., Ohta M., Miyamoto S, Nakayama A, Kanaya H, Oiwake II., Genda A., Takeda R: Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease., Circulation 1981:64: 1174-1184.
35. Steiner G: Diabetes and atherosclerosis., Diabetes 1981;30(suppl 2):1-7.
36. Kasama T, Yoshino G., lwatani I., Iwai M, Hatanaka H, Kazumi T, Oimomi M, Baba S: Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipi-demic non-insulin-dependent diabetics., Atherosclerosis 1987;63:263-266.
37. Duell PB., Bierman EL: Potential role of insulin in the clearance of remnant lipoproteins in dvs-betalipoproteinaemia., J Intern Med 1991:229: 97-101.
38. Shimizu H, Mori M, Saito T: An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria., Clin Chim Acta 1993;221:191-196